Target intelligence / Profile preview

Ascending Reticular Activating System (ARAS)

Target
ARAS
Molecular classification
Other
01

Overview

The cortical arousal system, scientifically known as the Ascending Reticular Activating System (ARAS), is a complex functional network of neurons originating in the brainstem and hypothalamus that projects to the thalamus and cerebral cortex (StatPearls, 2023). Its primary biological role is to regulate the transition between sleep and wakefulness, maintain consciousness, and mediate states of alertness and attention (Nature Reviews Neuroscience, 2005). The system integrates multiple neurotransmitter pathways, including cholinergic, noradrenergic, serotonergic, histaminergic, and orexinergic projections, to modulate global cortical activity (Journal of Comparative Neurology, 2011). Dysregulation of this system is a hallmark of various sleep disorders, such as narcolepsy and insomnia, and it is often compromised in neurodegenerative diseases and traumatic brain injuries (Frontiers in Neurology, 2018). While the system itself is a physiological network rather than a single molecular target, pharmacological interventions achieve therapeutic effects by targeting specific receptors and transporters within these pathways to either promote arousal or induce sedation (Neuropsychopharmacology, 2017).

Other names
Cortical arousal systemReticular activating systemWake-promoting systemArousal system
02

Mechanism of action

Drugs modulate the system by acting as agonists, antagonists, or reuptake inhibitors at specific molecular targets within the network, such as orexin receptors, histamine H3 receptors, or dopamine and norepinephrine transporters, to either enhance or suppress cortical excitability (Neuropsychopharmacology, 2017).

03

Biological functions

Regulation of wakefulnessConsciousnessAttentionSleep-wake cycle regulationArousal
04

Disease associations

InsomniaNarcolepsyHypersomniaAttention deficit hyperactivity disorderAlzheimer's diseaseParkinson's diseaseTraumatic brain injuryComa
05

Safety considerations

Potential for abuse and addictionCardiovascular stimulationPsychiatric side effects including anxiety and psychosisRebound insomniaCognitive impairmentDaytime somnolence
06

Interacting drugs

Modafinil

9 more in the full profile.

07

Biomarkers

Electroencephalography (EEG) power spectraPolysomnographyMultiple Sleep Latency Test (MSLT)Cerebrospinal fluid orexin-A levelsPupillometry

Beyond the preview

Go deeper on Ascending Reticular Activating System (ARAS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ascending Reticular Activating System (ARAS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call